These changes may account for the increase in calprotectin (marker of gut inflammation) and I-FABP (marker of gut epithelial integrity) we observed in women with T1D, known to be associated with impaired epithelial barrier function and leakage of LPS and other bacterial products leading to low-grade systemic inflammation. Here, FABP2 is linked to type 1 diabetes mellitus.